112 related articles for article (PubMed ID: 7743552)
1. Interleukin-6 inhibits apoptosis of malignant plasma cells.
Lichtenstein A; Tu Y; Fady C; Vescio R; Berenson J
Cell Immunol; 1995 May; 162(2):248-55. PubMed ID: 7743552
[TBL] [Abstract][Full Text] [Related]
2. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL.
Schwarze MM; Hawley RG
Cancer Res; 1995 Jun; 55(11):2262-5. PubMed ID: 7757973
[TBL] [Abstract][Full Text] [Related]
3. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
Ritke MK; Rusnak JM; Lazo JS; Allan WP; Dive C; Heer S; Yalowich JC
Mol Pharmacol; 1994 Oct; 46(4):605-11. PubMed ID: 7969039
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone induces apoptosis in human T cell clones expressing low levels of Bcl-2.
Gilardini Montani MS; Tuosto L; Giliberti R; Stefanini L; Cundari E; Piccolella E
Cell Death Differ; 1999 Jan; 6(1):79-86. PubMed ID: 10200551
[TBL] [Abstract][Full Text] [Related]
5. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
Li QF; Wu CT; Duan HF; Sun HY; Wang H; Lu ZZ; Zhang QW; Liu HJ; Wang LS
Br J Haematol; 2007 Sep; 138(5):632-9. PubMed ID: 17686057
[TBL] [Abstract][Full Text] [Related]
6. A role for the intermediate affinity IL-2R in the protection against glucocorticoid-induced apoptosis.
Rebollo A; Pitton C; García A; Gómez J; Silva A
Immunology; 1995 Mar; 84(3):388-95. PubMed ID: 7751021
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
Walton MI; Whysong D; O'Connor PM; Hockenbery D; Korsmeyer SJ; Kohn KW
Cancer Res; 1993 Apr; 53(8):1853-61. PubMed ID: 8467505
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1.
Carollo M; Parente L; D'Alessandro N
Oncol Res; 1998; 10(5):245-54. PubMed ID: 9802059
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
Dole M; Nuñez G; Merchant AK; Maybaum J; Rode CK; Bloch CA; Castle VP
Cancer Res; 1994 Jun; 54(12):3253-9. PubMed ID: 8205548
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
11. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
Walker A; Taylor ST; Hickman JA; Dive C
Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
[TBL] [Abstract][Full Text] [Related]
12. IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells.
Sade H; Sarin A
Eur J Immunol; 2003 Apr; 33(4):913-9. PubMed ID: 12672057
[TBL] [Abstract][Full Text] [Related]
13. Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line.
Ogawa M; Nishiura T; Oritani K; Yoshida H; Yoshimura M; Okajima Y; Ishikawa J; Hashimoto K; Matsumura I; Tomiyama Y; Matsuzawa Y
Cancer Res; 2000 Aug; 60(15):4262-9. PubMed ID: 10945640
[TBL] [Abstract][Full Text] [Related]
14. Activation of N-ras and K-ras induced by interleukin-6 in a myeloma cell line: implications for disease progression and therapeutic response.
Rowley M; Van Ness B
Oncogene; 2002 Dec; 21(57):8769-75. PubMed ID: 12483530
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis is accompanied by changes in Bcl-2 and Bax expression, induced by loss of attachment, and inhibited by specific extracellular matrix proteins in mammary epithelial cells.
Merto GR; Cella N; Hynes NE
Cell Growth Differ; 1997 Feb; 8(2):251-60. PubMed ID: 9040947
[TBL] [Abstract][Full Text] [Related]
16. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.
Li L; Krajewski S; Reed JC; Choi YS
Cell Immunol; 1997 May; 178(1):33-41. PubMed ID: 9184696
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-3 and Bcl-2 cooperatively inhibit etoposide-induced apoptosis in a murine pre-B cell line.
Ascaso R; Marvel J; Collins MK; López-Rivas A
Eur J Immunol; 1994 Mar; 24(3):537-41. PubMed ID: 7510234
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
Moreno MB; Memon SA; Zacharchuk CM
J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of cytokine signals for proliferation and apoptosis.
Shi Y; Wang R; Sharma A; Gao C; Collins M; Penn L; Mills GB
J Immunol; 1997 Dec; 159(11):5318-28. PubMed ID: 9548471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]